Microprocessor-Controlled Prostheses for the Lower Limb (L5615)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Medical coverage criteria for microprocessor-controlled prosthetic knees for individuals with transfemoral amputation, describing when L5615 is considered medically necessary for Medicare Advantage and commercial products and who should be evaluated.
No material clinical or coverage changes in this revision.
Coverage criteria for microprocessor-controlled knees
Medical necessity criteria for microprocessor-controlled knees (L5615)
Covered when ALL of the following are met for individuals with transfemoral amputation:
The policy lists several specific exclusions and contraindications that would make a microprocessor-controlled knee inappropriate and may lead to non‑coverage or denial. These include: inability to fit a socket (for example, a complicated wound or intractable pain that precludes socket wear), inability to tolerate the weight of the prosthesis, and Medicare functional levels K0 (no ability or potential to ambulate or transfer) or K1 (limited ability to transfer or ambulate on level ground at a fixed cadence). Other clinical contraindications noted are inability to use the device’s swing and stance features, poor balance or ataxia, significant hip flexion contracture (>20°), significant deformity impairing stride, limited cardiovascular/pulmonary reserve or profound weakness, limited cognitive ability to manage gait sequencing and device care, activities outside device weight/height limits, and environmental or maintenance limitations (eg, excessive moisture/dust, inability to charge, or extremely rural settings limiting maintenance).
The microprocessor knee is not considered medically necessary when the residual limb will be used only for home or basic community ambulation, or when the patient’s needs are limited to occasional or limited stair climbing in the home or work setting. The policy specifies that use of the limb in the home or for basic community ambulation alone is insufficient to justify the computerized limb over a standard prosthesis. Benefits may vary by contract, so refer to the member’s Benefit Booklet or Evidence of Coverage for specific coverage determinations.
HCPCS coding and related measures
| L5615 | Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control |
| K1014 | Former code referenced for dates of service prior to 1/1/2024 |
| L5856 | Microprocessor-controlled prosthesis code referenced (use online tool for participating providers) |
| L5857 | Microprocessor-controlled prosthesis code referenced (use online tool for participating providers) |
| L5858 | Microprocessor-controlled prosthesis code referenced (use online tool for participating providers) |
| L5973 | Microprocessor-controlled prosthesis code referenced (use online tool for participating providers) |
Prior authorization, documentation, and trial requirements
Prior authorization and web-based DME tool — HCPCS L5615 guidance
Prior authorization must follow the payer's related DME web-based tool processes; criteria in this policy apply specifically to HCPCS L5615 for Medicare Advantage and Commercial Products. For other microprocessor-controlled lower-limb prosthesis HCPCS codes (L5856, L5857, L5858, L5973) providers must use the online tool for participating providers per the related DME prior authorization policy.
Trial with a standard (non-microprocessor) prosthesis before microprocessor knee
When benefit is uncertain, fit the individual with a standard (non-microprocessor) prosthesis first to evaluate functional level and tolerance before providing a microprocessor knee.
- A trial period may be indicated to evaluate tolerability and efficacy in a real-life setting.
- Use trial results (functional performance with the standard device) to determine need for microprocessor-controlled knee.
Required clinical documentation to support L5615 requests
Document transfemoral amputation level, Medicare Functional Classification (K-) level, and clinical evidence demonstrating need for ambulation that meets the policy thresholds and functional requirements.
- Evidence of transfemoral (or specified higher) amputation level and ability to fit a socket with stable wound status.
- Specify Medicare K-level (K2, K3, or K4) and describe cardiovascular/pulmonary reserve, strength, balance, and cognitive ability to use the device.
- Document demonstrated ambulatory need (e.g., daily continuous ambulation ≥400 yards, frequent variable cadence ambulation, uneven terrain, or regular stair use).
Clinical contraindications that may trigger denial
Be aware that specific clinical contraindications will make the microprocessor knee inappropriate and may lead to non-coverage or denial.
- Conditions preventing socket fitting (e.g., complicated wound or intractable pain) or inability to tolerate prosthesis weight.
- Medicare K0 or K1 status, poor balance/ataxia, inability to use swing and stance features, significant hip flexion contracture (>20°), or deformity impairing stride.
- Limited cardiovascular/pulmonary reserve or profound weakness, device weight/height outside manufacturer guidelines, or environmental/maintenance limitations (excessive moisture/dust, inability to charge, extremely rural settings).
Background on microprocessor-controlled prostheses
Microprocessor-controlled prostheses use feedback from sensors to adjust joint movement on a real‑time, as‑needed basis and provide active control during stance and swing phases of gait. This sensor-driven, real‑time joint control allows the device to respond to changing terrain and variable walking speeds, improving safety and function—particularly for ambulation on uneven surfaces, ramps, and stairs—and can reduce energy expenditure for active walkers. Because effective use depends on the wearer’s cardiovascular reserve, strength, balance, and cognitive ability, candidates should be evaluated by a qualified professional and may require a trial period with a standard prosthesis to assess potential benefit.
Definitions used in this policy
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.